BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9536289)

  • 1. Aggrecanase and metalloproteinase-specific aggrecan neo-epitopes are induced in the articular cartilage of mice with collagen II-induced arthritis.
    Singer II; Scott S; Kawka DW; Bayne EK; Weidner JR; Williams HR; Mumford RA; Lark MW; McDonnell J; Christen AJ; Moore VL; Mudgett JS; Visco DM
    Osteoarthritis Cartilage; 1997 Nov; 5(6):407-18. PubMed ID: 9536289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
    Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
    J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis.
    Singer II; Kawka DW; Bayne EK; Donatelli SA; Weidner JR; Williams HR; Ayala JM; Mumford RA; Lark MW; Glant TT
    J Clin Invest; 1995 May; 95(5):2178-86. PubMed ID: 7537757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the 'aggrecanase' and the MMP sites. Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan.
    Büttner FH; Hughes CE; Margerie D; Lichte A; Tschesche H; Caterson B; Bartnik E
    Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):159-65. PubMed ID: 9639575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity.
    van Meurs J; van Lent P; Stoop R; Holthuysen A; Singer I; Bayne E; Mudgett J; Poole R; Billinghurst C; van der Kraan P; Buma P; van den Berg W
    Arthritis Rheum; 1999 Oct; 42(10):2074-84. PubMed ID: 10524678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro.
    Hughes CE; Caterson B; Fosang AJ; Roughley PJ; Mort JS
    Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):799-804. PubMed ID: 7531436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase.
    Arner EC; Hughes CE; Decicco CP; Caterson B; Tortorella MD
    Osteoarthritis Cartilage; 1998 May; 6(3):214-28. PubMed ID: 9682788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interglobular domain of cartilage aggrecan is cleaved by hemorrhagic metalloproteinase HT-d (atrolysin C) at the matrix metalloproteinase and aggrecanase sites.
    Tortorella MD; Pratta MA; Fox JW; Arner EC
    J Biol Chem; 1998 Mar; 273(10):5846-50. PubMed ID: 9488721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 45 kDa collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases.
    Stanton H; Ung L; Fosang AJ
    Biochem J; 2002 May; 364(Pt 1):181-90. PubMed ID: 11988091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and novel distribution of matrix metalloproteinase-derived aggrecan fragments in porcine cartilage explants.
    Fosang AJ; Last K; Stanton H; Weeks DB; Campbell IK; Hardingham TE; Hembry RM
    J Biol Chem; 2000 Oct; 275(42):33027-37. PubMed ID: 10882746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases and aggrecanases cleave aggrecan in different zones of normal cartilage but colocalize in the development of osteoarthritic lesions in STR/ort mice.
    Chambers MG; Cox L; Chong L; Suri N; Cover P; Bayliss MT; Mason RM
    Arthritis Rheum; 2001 Jun; 44(6):1455-65. PubMed ID: 11407708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of aggrecanase- and metalloproteinase-induced neoepitopes in various stages of cartilage destruction in murine arthritis.
    van Meurs JB; van Lent PL; Holthuysen AE; Singer II; Bayne EK; van den Berg WB
    Arthritis Rheum; 1999 Jun; 42(6):1128-39. PubMed ID: 10366105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.
    Struglics A; Larsson S; Pratta MA; Kumar S; Lark MW; Lohmander LS
    Osteoarthritis Cartilage; 2006 Feb; 14(2):101-13. PubMed ID: 16188468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the interglobular domain of aggrecan alter matrix metalloproteinase and aggrecanase cleavage patterns. Evidence that matrix metalloproteinase cleavage interferes with aggrecanase activity.
    Mercuri FA; Maciewicz RA; Tart J; Last K; Fosang AJ
    J Biol Chem; 2000 Oct; 275(42):33038-45. PubMed ID: 11032846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent.
    Fosang AJ; Last K; Maciewicz RA
    J Clin Invest; 1996 Nov; 98(10):2292-9. PubMed ID: 8941646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin A inhibition of aggrecanase-mediated proteoglycan catabolism in articular cartilage.
    Little CB; Hughes CE; Curtis CL; Jones SA; Caterson B; Flannery CR
    Arthritis Rheum; 2002 Jan; 46(1):124-9. PubMed ID: 11817583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intact aggrecan and fragments generated by both aggrecanse and metalloproteinase-like activities are present in the developing and adult rat spinal cord and their relative abundance is altered by injury.
    Lemons ML; Sandy JD; Anderson DK; Howland DR
    J Neurosci; 2001 Jul; 21(13):4772-81. PubMed ID: 11425904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage.
    Collins-Racie LA; Flannery CR; Zeng W; Corcoran C; Annis-Freeman B; Agostino MJ; Arai M; DiBlasio-Smith E; Dorner AJ; Georgiadis KE; Jin M; Tan XY; Morris EA; LaVallie ER
    Matrix Biol; 2004 Jul; 23(4):219-30. PubMed ID: 15296936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of aggrecanase- and MMP-generated catabolic neoepitopes in the rat iodoacetate model of cartilage degeneration.
    Janusz MJ; Little CB; King LE; Hookfin EB; Brown KK; Heitmeyer SA; Caterson B; Poole AR; Taiwo YO
    Osteoarthritis Cartilage; 2004 Sep; 12(9):720-8. PubMed ID: 15325638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.